drugset / Trial / NCT02814500
DP-R212 Pharmacokinetic Study Phase I
RandomizedCrossoverOpen-labelTreatment
Summary
An open label, randomized, 2-sequence, 2-period, single-dose cross-over study to evaluate the pharmacokinetics characteristics of DP-R212
Timeline
- Start
- 2016-07
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | — | — |
| Subject | DP-R212 | Unknown | — | — |
| Subject | Rosuvastatin | Small molecule | — | — |
Indications
No indication recorded.